Loading…
Pill Mill Crackdown Act of 2011
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
7d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (10)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2012 · fourth_quarter · Alcohol and Drug Abuse
Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Addiction treatment issues. Addition to #17 below: Center for Substance Abuse Treatment (CSAT) Public Law 110-343, Emergency Economic Stabilization Act of 2008, Regulations implementation, Mental health and addiction parity President's Budget, FY2013, Addiction treatment and workforce issues Public Law 111-148, Patient Protection and Affordable Care Act, Addiction treatment issues. H.R.1065, Pill Mill Crackdown Act of 2011, Addiction treatment issues.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2012 · fourth_quarter · Pharmacy
H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; S.2297 relating to hydrocodone rescheduling. H.R. 5853 - Gray Market Drug Reform and Transparency Act of 2012
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Health Issues
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Client expense: $510,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2012 · third_quarter · Health Issues
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Client expense: $510,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2012 · fourth_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297) Drug Abuse (S. 507) Drug Shortages (S. 296/H.R. 2245/H.R. 3839/PL 112-144/H.R. 5853/H.R. 5651) Rx Pedigree (H.R. 3026/PL 112-144) Cargo/Product Theft (S. 1002/H.R. 4223) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292/PL 112-144) Counterfeit Drugs (S. 1886/H.R. 3668/PL 112-144) ***, no specific bills, supply chain integrity, prescription drug abuse
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Alcohol and Drug Abuse
H.R.1065- Pill Mill Crackdown Act of 2011 H.R.1254-Synthetic Drug Control Act of 2011 H.R.1571-Combating Dangerous Synthetic Stimulants Act of 2011 H.R.1925-Prescription Drug Abuse Prevention and Treatment Act of 2011 H.R.2119-Ryan Creedon Act of 2011 H.R.2324-Research of Alcohol Detection Systems (ROADS) for Stopping Alcohol-related Fatalities Everywhere Act of 2011 H.R.3668-Counterfeit Drug Penalty Enhancement Act of 2012 S.409-Combating Dangerous Synthetic Stimulants Act of 2011 S.507-Prescription Drug Abuse Prevention and Treatment Act of 2011 S.510-Research of Alcohol Detection Systems (ROADS) for Stopping Alcohol-related Fatalities Everywhere Act of 2011 S.605-Dangerous Synthetic Drug Control Act of 2011 S.839-Combating Designer Drugs Act of 2011 S.1760-Pill Mill Crackdown Act of 2011
Client expense: $695,377 · Firm income: Not reported
2012 · fourth_quarter · Consumer Issues/Safety/Products
H.R.866-National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2011 H.R.1065- Pill Mill Crackdown Act of 2011 H.R.1254-Synthetic Drug Control Act of 2011 H.R.1571-Combating Dangerous Synthetic Stimulants Act of 2011 H.R.2245-Preserving Access to Life-Saving Medications Act of 2011 H.R.3668-Counterfeit Drug Penalty Enhancement Act of 2012 H.R.5651-Food and Drug Administration Safety and Innovation Act S.296-Preserving Access to Life-Saving Medications Act S.409-Combating Dangerous Synthetic Stimulants Act of 2011 S.605-Dangerous Synthetic Drug Control Act of 2011 S.839-Combating Designer Drugs Act of 2011 S.1760-Pill Mill Crackdown Act of 2011 S.2516-Food and Drug Administration Safety and Innovation Act S.3187-Food and Drug Administration Safety and Innovation Act
Client expense: $695,377 · Firm income: Not reported
2012 · fourth_quarter · Pharmacy
Rx Pedigree (H.R. 3026/PL 112-144); NASPER Reauthorization (H.R. 866); Prescription Drug Monitoring Programs (S. 2254/H.R. 4292/PL 112-144); Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297); Drug Abuse (S. 507); Drug Shortages (S. 296/HR 2245/HR 3839/ PL 112-144/HR 5853/HR 5651); Cargo/Product Theft (S. 1002/H.R. 4223; PL 112-204); Counterfeit Drugs (S. 1886/H.R. 3668/PL 112-144)
Client expense: $228,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · third_quarter · Health Issues
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Client expense: $380,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297) Drug Abuse (S. 507) Drug Shortages (S. 296/H.R. 2245/H.R. 3839/S.3187/H.R. 5853/H.R. 5651) Rx Pedigree (H.R. 3026/S. 3187) Cargo/Product Theft (S. 1002/H.R. 4223) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292/S. 3187) Counterfeit Drugs (S. 1886/H.R. 3668/S. 3187) ***, no specific bills, supply chain integrity, prescription drug abuse
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Alcohol and Drug Abuse
Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Addiction treatment issues. Addition to #17 below: Center for Substance Abuse Treatment (CSAT) Public Law 110-343, Emergency Economic Stabilization Act of 2008, Regulations implementation, Mental health and addiction parity President's Budget, FY2013, Addiction treatment and workforce issues Public Law 111-148, Patient Protection and Affordable Care Act, Addiction treatment issues. H.R.1065, Pill Mill Crackdown Act of 2011, Addiction treatment issues.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2012 · third_quarter · Alcohol and Drug Abuse
H.R.1065- Pill Mill Crackdown Act of 2011 H.R.1254-Synthetic Drug Control Act of 2011 H.R.1571-Combating Dangerous Synthetic Stimulants Act of 2011 H.R.1925-Prescription Drug Abuse Prevention and Treatment Act of 2011 H.R.2119-Ryan Creedon Act of 2011 H.R.2324-Research of Alcohol Detection Systems (ROADS) for Stopping Alcohol-related Fatalities Everywhere Act of 2011 H.R.3668-Counterfeit Drug Penalty Enhancement Act of 2012 S.409-Combating Dangerous Synthetic Stimulants Act of 2011 S.507-Prescription Drug Abuse Prevention and Treatment Act of 2011 S.510-Research of Alcohol Detection Systems (ROADS) for Stopping Alcohol-related Fatalities Everywhere Act of 2011 S.605-Dangerous Synthetic Drug Control Act of 2011 S.839-Combating Designer Drugs Act of 2011 S.1760-Pill Mill Crackdown Act of 2011
Client expense: $433,244 · Firm income: Not reported
2012 · third_quarter · Consumer Issues/Safety/Products
H.R.866-National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2011 H.R.1065- Pill Mill Crackdown Act of 2011 H.R.1254-Synthetic Drug Control Act of 2011 H.R.1571-Combating Dangerous Synthetic Stimulants Act of 2011 H.R.2245-Preserving Access to Life-Saving Medications Act of 2011 H.R.3668-Counterfeit Drug Penalty Enhancement Act of 2012 H.R.5651-Food and Drug Administration Safety and Innovation Act S.296-Preserving Access to Life-Saving Medications Act S.409-Combating Dangerous Synthetic Stimulants Act of 2011 S.605-Dangerous Synthetic Drug Control Act of 2011 S.839-Combating Designer Drugs Act of 2011 S.1760-Pill Mill Crackdown Act of 2011 S.2516-Food and Drug Administration Safety and Innovation Act S.3187-Food and Drug Administration Safety and Innovation Act
Client expense: $433,244 · Firm income: Not reported
2012 · third_quarter · Pharmacy
Rx Pedigree (H.R. 3026/S. 3187); NASPER Reauthorization (H.R. 866); Prescription Drug Monitoring Programs (S. 2254/H.R. 4292/S.3187); Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297); Drug Abuse (S. 507); Drug Shortages (S. 296/ H.R. 2245/H.R. 3839/S. 3187/H.R. 5853/H.R. 5651); Cargo/Product Theft (S. 1002/H.R. 4223); Counterfeit Drugs (S. 1886/H.R. 3668/S. 3187)
Client expense: $222,819 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · third_quarter · Pharmacy
H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; S.2997 relating to hydrocodone rescheduling.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Health Issues
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Client expense: $510,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Health Issues
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Client expense: $470,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Alcohol and Drug Abuse
H.R.1065- Pill Mill Crackdown Act of 2011 H.R.1254-Synthetic Drug Control Act of 2011 H.R.1571-Combating Dangerous Synthetic Stimulants Act of 2011 H.R.1925-Prescription Drug Abuse Prevention and Treatment Act of 2011 H.R.2119-Ryan Creedon Act of 2011 H.R.2324-Research of Alcohol Detection Systems (ROADS) for Stopping Alcohol-related Fatalities Everywhere Act of 2011 H.R.3668-Counterfeit Drug Penalty Enhancement Act of 2012 S.409-Combating Dangerous Synthetic Stimulants Act of 2011 S.507-Prescription Drug Abuse Prevention and Treatment Act of 2011 S.510-Research of Alcohol Detection Systems (ROADS) for Stopping Alcohol-related Fatalities Everywhere Act of 2011 S.605-Dangerous Synthetic Drug Control Act of 2011 S.839-Combating Designer Drugs Act of 2011 S.1760-Pill Mill Crackdown Act of 2011
Client expense: $891,775 · Firm income: Not reported
2012 · second_quarter · Consumer Issues/Safety/Products
H.R.1065- Pill Mill Crackdown Act of 2011 H.R.1254-Synthetic Drug Control Act of 2011 H.R.1571-Combating Dangerous Synthetic Stimulants Act of 2011 H.R.2245-Preserving Access to Life-Saving Medications Act of 2011 H.R.3668-Counterfeit Drug Penalty Enhancement Act of 2012 H.R.5651-Food and Drug Administration Safety and Innovation Act S.296-Preserving Access to Life-Saving Medications Act S.409-Combating Dangerous Synthetic Stimulants Act of 2011 S.605-Dangerous Synthetic Drug Control Act of 2011 S.839-Combating Designer Drugs Act of 2011 S.1760-Pill Mill Crackdown Act of 2011 S.2516-Food and Drug Administration Safety and Innovation Act S.3187-Food and Drug Administration Safety and Innovation Act
Client expense: $891,775 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Consumer Issues/Safety/Products
H.R.1065- Pill Mill Crackdown Act of 2011 H.R.1254-Synthetic Drug Control Act of 2011 H.R.1571-Combating Dangerous Synthetic Stimulants Act of 2011 H.R.2245-Preserving Access to Life-Saving Medications Act of 2011 H.R.3668-Counterfeit Drug Penalty Enhancement Act of 2012 H.R.5651-Food and Drug Administration Safety and Innovation Act S.296-Preserving Access to Life-Saving Medications Act S.409-Combating Dangerous Synthetic Stimulants Act of 2011 S.605-Dangerous Synthetic Drug Control Act of 2011 S.839-Combating Designer Drugs Act of 2011 S.1760-Pill Mill Crackdown Act of 2011 S.2516-Food and Drug Administration Safety and Innovation Act S.3187-Food and Drug Administration Safety and Innovation Act
Client expense: $891,775 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Alcohol and Drug Abuse
H.R.1065- Pill Mill Crackdown Act of 2011 H.R.1254-Synthetic Drug Control Act of 2011 H.R.1571-Combating Dangerous Synthetic Stimulants Act of 2011 H.R.1925-Prescription Drug Abuse Prevention and Treatment Act of 2011 H.R.2119-Ryan Creedon Act of 2011 H.R.2324-Research of Alcohol Detection Systems (ROADS) for Stopping Alcohol-related Fatalities Everywhere Act of 2011 H.R.3668-Counterfeit Drug Penalty Enhancement Act of 2012 S.409-Combating Dangerous Synthetic Stimulants Act of 2011 S.507-Prescription Drug Abuse Prevention and Treatment Act of 2011 S.510-Research of Alcohol Detection Systems (ROADS) for Stopping Alcohol-related Fatalities Everywhere Act of 2011 S.605-Dangerous Synthetic Drug Control Act of 2011 S.839-Combating Designer Drugs Act of 2011 S.1760-Pill Mill Crackdown Act of 2011
Client expense: $891,775 · Firm income: Not reported
2012 · second_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297) Drug Abuse (S. 507) Drug Shortages (S. 296/H.R. 2245/H.R. 3839/S.3187/H.R. 5853/H.R. 5651) Rx Pedigree (H.R. 3026/S. 3187) Cargo/Product Theft (S. 1002/H.R. 4223) Import Safety (S. 1584) Drug Importation (H.R. 2112 - Agriculture, Transportation Appropriations Bill for 2012) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292/S. 3187) Counterfeit Drugs (S. 1886/H.R. 3668/S. 3187) Internet Pharmacey (S. 2002/H.R. 4095) ***, no specific bills: supply chain integrity, prescription drug abuse, internet pharmacy regulation
Client expense: Not reported · Firm income: $60,000
2012 · second_quarter · Pharmacy
Drug shortages - Proposed legislation re these issues. Opiate abuse - HR 1316, Stop Oxy Abuse Act of 2011; HR 2119, Ryan Creedon Act of 2011; HR 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011; HR 1065, Pill Mill Crackdown Act of 2011; S 507, Prescription Drug Abuse Prevention and Treatment Act of 2011; Executive Branch action re this issue. Pharmaceutical issues, including tracking and tracing medicines, fostering competition between generic and brand-name pharmaceutical manufacturers - HR 5651, Food and Drug Administration Reform Act of 2012; S 3187, Food and Drug Administration Safety and Innovation Act. Incentives to develop antibiotics - HR 2182, Generating Antibiotic Incentives Now Act of 2011; S 1734, Generating Antibiotic Incentives Now Act of 2011. Establish criminal penalties for trafficking in counterfeit drugs - HR 3468, Counterfeit Drug Penalty Enhancement Act of 2011; S 1886, Counterfeit Drug Penalty Enhancement Act of 2011. National Center for Advancing Transformational Sciences at FDA; agreement to review compounds for potential new uses - Executive Branch actions re these issues. *Follow-on biologics generally. *Certified Importer Program. *Drug safety - HR 1483, Drug Safety Enhancement Act of 2011.
Client expense: Not reported · Firm income: $100,000
2012 · second_quarter · Pharmacy
Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R. 5651 & S. 2516 & S.3187 to drug shortages
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Pharmacy
Importation of Prescription Drugs (S. 319, H.R. 147); Rx Pedigree (H.R. 3026/S. 3187); NASPER Reauthorization (H.R. 866); Presecription Drug Monitoring Programs (S. 2254/H.R. 4292/S. 3187); Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297); Drug Abuse (S. 507); Drug Shortages (S. 296/ H.R. 2245/H.R. 3839/S. 3187/H.R. 5853/H.R. 5651); Cargo/Product Theft (S.1002/H.R. 4223); Import Safety(S.1584); Counterfeit Drugs(S.1886/H.R. 3668/S.3187); Internet Pharmacy(S.2002/H.R. 4095)
Client expense: $323,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Alcohol and Drug Abuse
Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Addiction treatment issues. Addition to #17 below: National Institute of Drug Abuse (NIDA); Center for Substance Abuse Treatment (CSAT) Public Law 110-343, Emergency Economic Stabilization Act of 2008, Regulations implementation, Mental health and addiction parity President's Budget, FY2013, Addiction treatment and workforce issues Public Law 111-148, Patient Protection and Affordable Care Act, Addiction treatment issues. H.R.1065, Pill Mill Crackdown Act of 2011, Addiction treatment issues.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2012 · first_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760) Drug Abuse (S. 507) Drug Stortages (S. 296/H.R. 2245/H.R. 3839) Rx Pedigree (H.R. 3026) Cargo/Product Theft (S. 1002/H.R. 4223) Import Safety (S. 1584) Drug Importation (H.R. 2112 - Agriculture, Transportation Appropriations Bill for 2012) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292) Counterfeit Drugs (S. 1886/H.R. 3668) Internet Pharmacey (S. 2002/H.R. 4095) ***, no specific bills, federal pedigree, import safety
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Health Issues
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Client expense: $490,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Alcohol and Drug Abuse
H.R.1065-Pill Mill Crackdown Act of 2011 H.R.1254-Synthetic Drug Control Act of 2011 H.R.1571-Combating Dangerous Synthetic Stimulants Act of 2011 H.R.1925-Prescription Drug Abuse Prevention and Treatment Act of 2011 H.R.2119-Ryan Creedon Act of 2011 H.R.2324-Research of Alcohol Detection Systems (ROADS) for Stopping Alcohol-related Fatalities Everywhere Act of 2011 S.409-Combating Dangerous Synthetic Stimulants Act of 2011 S.507-Prescription Drug Abuse Prevention and Treatment Act of 2011 S.510-Research of Alcohol Detection Systems (ROADS) for Stopping Alcohol-related Fatalities Everywhere Act of 2011 S.1760-Pill Mill Crackdown Act of 2011 S.605-Dangerous Synthetic Drug Control Act of 2011 S.839-Combating Designer Drugs Act of 2011
Client expense: $508,199 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Consumer Issues/Safety/Products
H.R.1065-Pill Mill Crackdown Act of 2011 H.R.1254-Synthetic Drug Control Act of 2011 H.R.1571-Combating Dangerous Synthetic Stimulants Act of 2011 H.R.2245-Preserving Access to Life-Saving Medications Act of 2011 S.296-Preserving Access to Life-Saving Medications Act S.409-Combating Dangerous Synthetic Stimulants Act of 2011 S.1760-Pill Mill Crackdown Act of 2011 S.605-Dangerous Synthetic Drug Control Act of 2011 S.839-Combating Designer Drugs Act of 2011
Client expense: $508,199 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Alcohol and Drug Abuse
Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Addiction treatment issues. Addition to #17 below: National Institute of Drug Abuse (NIDA); Center for Substance Abuse Treatment (CSAT) Public Law 110-343, Emergency Economic Stabilization Act of 2008, Regulations implementation, Mental health and addiction parity President's Budget, FY2013, Addiction treatment and workforce issues Public Law 111-148, Patient Protection and Affordable Care Act, Addiction treatment issues. H.R.1065, Pill Mill Crackdown Act of 2011, Addiction treatment issues.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2012 · first_quarter · Pharmacy
Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R 2245, H.R. 3839 S. 296 Related to Drug Shortages S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011 H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 H.R. 4233 & S. 1002 - Safe Doses Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1886 & H.R. 3668 - Counterfeit Drug Penalty Enhancement Act of 2011 S. 2002 & H.R. 4095 - Online Pharmacy Safety Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Pharmacy
Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R 2245, H.R. 3839 S. 296 Related to Drug Shortages S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011 H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 H.R. 4233 & S. 1002 - Safe Doses Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1886 & H.R. 3668 - Counterfeit Drug Penalty Enhancement Act of 2011 S. 2002 & H.R. 4095 - Online Pharmacy Safety Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Pharmacy
Importation of Presceiption Drugs (S. 319, H.R. 147); Rx Pedigree (H.R. 3026/draft PDUFA legislation); NASPER Reauthorization (H.R. 866); Prescription Drug Monitoring Programs (S. 2254/H.R. 4292); Pill Mill Crackdown Act (H.R. 1065/S. 1760); Drug Abuse (S. 507); Drug Shortages (S. 296/H.R. 2245/H.R. 3839/draft PDUFA legislation); Cargo/Product Theft (S. 1002/H.R. 4223); Import Safety (S. 1584); Counterfeit Drugs (S. 1886/H.R. 3668); Internet Pharmacy (S. 2002/H.R. 4095)
Client expense: $282,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · fourth_quarter · Pharmacy
Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011 S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011 H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 S. 1002 - Safe Doses Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760) Drug Abuse (S. 507) Drug Stortages (S. 296/H.R. 2245) Rx Pedigree (H.R. 3026) Cargo/Product Theft (S. 1002) Import Safety (S. 1584) Drug Importation (H.R. 2112 - Agriculture, Transportation Appropriations Bill for 2012) **no specific bills, federal pedigree, import safety
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Alcohol and Drug Abuse
Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Addiction treatment issues. Addition to #17 below: National Institute of Drug Abuse (NIDA); Center for Substance Abuse Treatment (CSAT) Public Law 110-343, Emergency Economic Stabilization Act of 2008, Regulations implementation, Mental health and addiction parity President's Budget, FY2012, Addiction treatment and workforce issues Public Law 111-148, Patient Protection and Affordable Care Act, Addiction treatment issues. H.R.1065, Pill Mill Crackdown Act of 2011, Addiction treatment issues.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2011 · fourth_quarter · Health Issues
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Client expense: $520,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Alcohol and Drug Abuse
H.R.1065 - Pill Mill Crackdown Act of 2011 H.R.1254 - Synthetic Drug Control Act of 2011 H.R.1571 - Combating Dangerous Synthetic Stimulants Act of 2011 H.R.1925 - Prescription Drug Abuse Prevention and Treatment Act of 2011 H.R.2324 - Research of Alcohol Detection Systems (ROADS) for Stopping Alcohol-related Fatalities Everywhere Act of 2011 S.409 - Combating Dangerous Synthetic Stimulants Act of 2011 S.507 - Prescription Drug Abuse Prevention and Treatment Act of 2011 S.510 - Research of Alcohol Detection Systems (ROADS) for Stopping Alcohol-related Fatalities Everywhere Act of 2011 S.605 - Dangerous Synthetic Drug Control Act of 2011 S.839 - Combating Designer Drugs Act of 2011
Client expense: $605,518 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Consumer Issues/Safety/Products
H.R.1065 - Pill Mill Crackdown Act of 2011 H.R.1254 - Synthetic Drug Control Act of 2011 H.R.1571 - Combating Dangerous Synthetic Stimulants Act of 2011 H.R.2245 - Preserving Access to Life-Saving Medications Act of 2011 S.296 - Preserving Access to Life-Saving Medications Act S.409 - Combating Dangerous Synthetic Stimulants Act of 2011 S.605 - Dangerous Synthetic Drug Control Act of 2011 S.839 - Combating Designer Drugs Act of 2011 S.1760 - Pill Mill Crackdown Act of 2011
Client expense: $605,518 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Pharmacy
Importation of Preseciption Drugs (S.319, H.R. 147); Rx Pedigree (H.R. 3026); NASPER Reauthorization (H.R. 866); Pill Mill Crackdown Act (H.R. 1065/S. 1760); Drug Abuse (S. 507); Drug Shortages (S. 296/H.R. 2245); Cargo/Product Theft (S. 1002); Import Safety (S. 1584)
Client expense: $280,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · third_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.319/H.R. 147) Methamphetamine/Pseudoephedrine Regulation NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065) Drug Abuse (S. 507) Drug Stortages (S. 296/H.R. 2245) Rx Pedigree (H.R. 3206) Cargo/Product Theft (S. 1002) Import Safety (S. 1584) **no specific bills, federal pedigree, import safety
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Medicare/Medicaid
S. 668, Health Care Bureaucrats Elimination Act. S. 1173, Ambulatory Surgical Center Quality and Access Act of 2011. H.R. 2108, Ambulatory Surgical Center Quality and Access Act of 2011. S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3070, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 1065, Pill Mill Crackdown Act of 2011. H.R. 1316, Stop Oxy Abuse Act of 2011. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor appropriations process and federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).
Client expense: Not reported · Firm income: $60,000
2011 · third_quarter · Budget/Appropriations
S. 668, Health Care Bureaucrats Elimination Act. S. 1173, Ambulatory Surgical Center Quality and Access Act of 2011. H.R. 2108, Ambulatory Surgical Center Quality and Access Act of 2011. S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3070, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 1065, Pill Mill Crackdown Act of 2011. H.R. 1316, Stop Oxy Abuse Act of 2011. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor appropriations process and federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).
Client expense: Not reported · Firm income: $60,000
2011 · third_quarter · Medical/Disease Research/Clinical Labs
S. 668, Health Care Bureaucrats Elimination Act. S. 1173, Ambulatory Surgical Center Quality and Access Act of 2011. H.R. 2108, Ambulatory Surgical Center Quality and Access Act of 2011. S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3070, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 1065, Pill Mill Crackdown Act of 2011. H.R. 1316, Stop Oxy Abuse Act of 2011. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor appropriations process and federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).
Client expense: Not reported · Firm income: $60,000
2011 · third_quarter · Health Issues
S. 668, Health Care Bureaucrats Elimination Act. S. 1173, Ambulatory Surgical Center Quality and Access Act of 2011. H.R. 2108, Ambulatory Surgical Center Quality and Access Act of 2011. S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3070, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 1065, Pill Mill Crackdown Act of 2011. H.R. 1316, Stop Oxy Abuse Act of 2011. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor appropriations process and federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).
Client expense: Not reported · Firm income: $60,000
2011 · third_quarter · Health Issues
H.R. 5, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011: Provisions related to FDA and product liability H.R. 1065, Pill Mill Crackdown Act of 2011: Provisions related to prescription drug abuse H.R. 1266, Fraudulent Prescription Prevention Act of 2011: Provisions related to prescription drug abuse H.R. 2182, Generating Antibiotic Incentives Now Act of 2011: Provisions related to antibiotics and incentives H.R. 2119, Ryan Creedon Act of 2011: Provisions related to drug diversion H.R. 2245, Preserving Access to Life-Saving Medications Act of 2011: Provisions related to prescription drug shortages S. 218, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011: Provisions related to FDA and product liability S. 296, Preserving Access to Life-Saving Medications Act: Provisions related to prescription drug shortages S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011: Provisions related to importation S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011: Provisions related to prescription drug abuse S. 2672, Preserving Access to Orphan Drugs Act of 2011: Provisions related to orphan drug definition and health reform fee Health care reform implementation issues, including health reform fee and essential benefits General FDA related advocacy Prescription Drug User Fee Reauthorization Anti-counterfeiting issues Biopharmaceutical innovation policy issues
Client expense: $4,740,000 · Firm income: Not reported
2011 · third_quarter · Health Issues
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Client expense: $490,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Alcohol and Drug Abuse
Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Addiction treatment issues. Addition to #17 below: National Institute of Drug Abuse (NIDA); Center for Substance Abuse Treatment (CSAT) Public Law 110-343, Emergency Economic Stabilization Act of 2008, Regulations implementation, Mental health and addiction parity President's Budget, FY2012, Addiction treatment and workforce issues Public Law 111-148, Patient Protection and Affordable Care Act, Addiction treatment issues. Monitor Health care reform regarding Addiction treatment and workforce issues generally: H.R.2017, Continuing Appropriations Act, FY2012 H.R.2608, Continuing Appropriations Act, FY2012 H.R.1065, Pill Mill Crackdown Act of 2011, Addiction treatment issues.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2011 · third_quarter · Pharmacy
Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 - Pill Mill Crackdown Act of 2011; S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011; H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 S. 1002 - Safe Doses Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| FL |
| Bill Posey | Republican | FL |
| Bill Shuster | Republican | PA |
| Brett Guthrie | Republican | KY |
| Bruce L. Braley | Democratic | IA |
| Cathy McMorris Rodgers | Republican | WA |
| Christopher H. Smith | Republican | NJ |
| Corrine Brown | Democratic | FL |
| Dan Burton | Republican | IN |
| Daniel Lipinski | Democratic | IL |
| Darrell Issa | Republican | CA |
| Dave Camp | Republican | MI |
| David B. McKinley | Republican | WV |
| David P. Roe | Republican | TN |
| David Rivera | Republican | FL |
| Debbie Wasserman Schultz | Democratic | FL |
| Dennis A. Ross | Republican | FL |
| Diane Black | Republican | TN |
| Donna F. Edwards | Democratic | MD |
| E. Scott Rigell | Republican | VA |
| Edward J. Markey | Democratic | MA |
| Frederica S. Wilson | Democratic | FL |
| Harold Rogers | Republican | KY |
| Ileana Ros-Lehtinen | Republican | FL |
| J. Randy Forbes | Republican | VA |
| Jeff Miller | Republican | FL |
| Jerry Lewis | Republican | CA |
| Jerry McNerney | Democratic | CA |
| Jim Cooper | Democratic | TN |
| Joe Wilson | Republican | SC |
| John B. Larson | Democratic | CT |
| John J. Duncan, Jr. | Republican | TN |
| John L. Mica | Republican | FL |
| John W. Olver | Democratic | MA |
| Kathy Castor | Democratic | FL |
| Laura Richardson | Democratic | CA |
| Lee Terry | Republican | NE |
| Lynn A. Westmoreland | Republican | GA |
| Mario Diaz-Balart | Republican | FL |
| Marlin A. Stutzman | Republican | IN |
| Mary Bono Mack | Republican | CA |
| Mike Kelly | Republican | PA |
| Nick J. Rahall II | Democratic | WV |
| Patrick J. Tiberi | Republican | OH |
| Richard B. Nugent | Republican | FL |
| Rick Berg | Republican | ND |
| Robert E. Latta | Republican | OH |
| Scott R. Tipton | Republican | CO |
| Shelley Moore Capito | Republican | WV |
| Stephen F. Lynch | Democratic | MA |
| Steve Austria | Republican | OH |
| Steven C. LaTourette | Republican | OH |
| Thaddeus McCotter | Republican | MI |
| Theodore E. Deutch | Democratic | FL |
| Thomas J. Rooney | Republican | FL |
| William R. Keating | Democratic | MA |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office